Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial ; day:2 ; month:4 ; year:2024 ; pages:1-11
Journal of endocrinological investigation ; (2.4.2024), 1-11
- Urheber
-
Dei Cas, A.
Micheli, M. M.
Aldigeri, R.
Gardini, S.
Ferrari-Pellegrini, F.
Perini, M.
Messa, G.
Antonini, M.
Spigoni, V.
Cinquegrani, G.
Vazzana, A.
Moretti, V.
Caffarra, P.
Bonadonna, R. C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40618-024-02320-7
- URN
-
urn:nbn:de:101:1-2406162112487.656117112286
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dei Cas, A.
- Micheli, M. M.
- Aldigeri, R.
- Gardini, S.
- Ferrari-Pellegrini, F.
- Perini, M.
- Messa, G.
- Antonini, M.
- Spigoni, V.
- Cinquegrani, G.
- Vazzana, A.
- Moretti, V.
- Caffarra, P.
- Bonadonna, R. C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Proof-of-concept study for a long-acting formulation of ivermectin injected in cattle as a complementary malaria vector control tool
Long-Acting Reversible Contraception
Inducing Affective Learning Biases with Cognitive Training and Prefrontal tDCS: A Proof-of-Concept Study
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Buying time: a proof-of-concept randomized controlled trial to improve sleep quality and cognitive function among older adults with mild cognitive impairment
Creation of a long-acting nanoformulated dolutegravir
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Customized virtual reality naturalistic scenarios promoting engagement and relaxation in patients with cognitive impairment: a proof-of-concept mixed-methods study
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
Proof-of-concept study for a long-acting formulation of ivermectin injected in cattle as a complementary malaria vector control tool
Long-Acting Reversible Contraception
Inducing Affective Learning Biases with Cognitive Training and Prefrontal tDCS: A Proof-of-Concept Study
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Buying time: a proof-of-concept randomized controlled trial to improve sleep quality and cognitive function among older adults with mild cognitive impairment
Creation of a long-acting nanoformulated dolutegravir
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Customized virtual reality naturalistic scenarios promoting engagement and relaxation in patients with cognitive impairment: a proof-of-concept mixed-methods study
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
Proof-of-concept study for a long-acting formulation of ivermectin injected in cattle as a complementary malaria vector control tool
Long-Acting Reversible Contraception
Inducing Affective Learning Biases with Cognitive Training and Prefrontal tDCS: A Proof-of-Concept Study
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Buying time: a proof-of-concept randomized controlled trial to improve sleep quality and cognitive function among older adults with mild cognitive impairment
Creation of a long-acting nanoformulated dolutegravir
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Customized virtual reality naturalistic scenarios promoting engagement and relaxation in patients with cognitive impairment: a proof-of-concept mixed-methods study